Melatonin

• ACUMEN: Acute High Dose Melatonin for Encephalopathy of the Newborn Pending
  2025-520538-49-00 Phase I 1 country University College London
• Melatonin versus quetiapine in adolescents (MEL-QUE-A) Recruiting
  2024-519597-39-00 Phase II/III 1 country Psykiatrisk Center Kobenhavn
• The M-bipolar RCT Recruiting
  2025-523549-92-00 Phase III/IV 1 country Region Hovedstaden
• CombiChronoS - Effectiveness of a Combination of Chronotherapeutics for the Treatment of Major Depressive Episode (MDE) with Insomnia: A Mul… Recruiting
  2024-516371-32-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Melatonin for patients with chronic low back pain - a randomized placebo-controlled trial Recruiting
  2024-514769-20-00 Phase III 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
• A randomized, double-blind, placebo-controlled, multicenter study evaluating the effect of a 12-week DHEA combination of 20 mg and 2 mg prol… Recruiting
  2024-520234-30-00 Phase III 1 country Przedsiebiorstwo Farmaceutyczne Lek-Am Sp. z o.o.; The Pharmaceutical Company LE…
• HyperChrono Recruiting
  2023-506663-33-00 Phase II 1 country Les Hopitaux Universitaires De Strasbourg
• Efficacy of melatonin, low-dose quetiapine, or placebo in patients with psychiatric disorders and comorbid insomnia: a randomized clinical t… Recruiting
  2023-504728-24-00 Phase II/III 1 country Psykiatrisk Center Kobenhavn; Region Hovedstadens Psykiatriske
• AMUM trial -Adjuvant Melatonin for Uveal Melanoma: A randomized open Phase III Study Recruiting
  2022-500307-49-00 Phase III 1 country St Erik Eye Hospital
• Melatonin for prevention of agitation after surgery in children (MELA-PAED). Ended
  2024-517592-20-00 Phase III 1 country Rigshospitalet
• Melatonin for Chronic back pain Ended
  2023-503530-41-00 Phase III 1 country Odense University Hospital

Showing 1–11 of 11 trials